Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews

AL Oaklander, MPT Lunn, RAC Hughes… - Cochrane Database …, 2017 - cochranelibrary.com
Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a
chronic progressive or relapsing and remitting disease that usually causes weakness and …

Immunosuppression for the Uveitides

DA Jabs - Ophthalmology, 2018 - Elsevier
The uveitides are a collection of more than 30 diseases characterized by intraocular
inflammation. Many cases of juvenile idiopathic arthritis–associated uveitis, many cases of …

European evidence-based consensus: inflammatory bowel disease and malignancies

V Annese, L Beaugerie, L Egan… - Journal of Crohn's …, 2015 - academic.oup.com
The global prevalence of cancer is increasing, largely as more patients are living into old
age. Therefore, gastroenterologists caring for patients with inflammatory bowel disease [IBD] …

Expert panel recommendations for the use of anti–tumor necrosis factor biologic agents in patients with ocular inflammatory disorders

G Levy-Clarke, DA Jabs, RW Read, JT Rosenbaum… - Ophthalmology, 2014 - Elsevier
Topic To provide recommendations for the use of anti-tumor necrosis factor α (TNF-α)
biologic agents in patients with ocular inflammatory disorders. Clinical Relevance Ocular …

The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management

CS Foster, S Kothari, SD Anesi, AT Vitale, D Chu… - Survey of …, 2016 - Elsevier
Ocular inflammatory disease is a leading cause of vision loss worldwide. Uveitis
encompasses a wide spectrum of pathology, both with respect to its etiology and the …

Adverse effects of biologics used for treating IBD

A Stallmach, S Hagel, T Bruns - Best practice & research Clinical …, 2010 - Elsevier
In the last decade, biologic agents, in particular anti-TNF agents such as infliximab,
adalimumab, and certolizumab have substantially extended the therapeutic armamentarium …

Azathioprine for ocular inflammatory diseases

S Pasadhika, JH Kempen, CW Newcomb… - American journal of …, 2009 - Elsevier
PURPOSE: To evaluate treatment outcomes of azathioprine for noninfectious ocular
inflammatory diseases. DESIGN: Retrospective cohort study. METHODS: Medical records of …

Mycophenolate mofetil for ocular inflammation

E Daniel, JE Thorne, CW Newcomb, SS Pujari… - American journal of …, 2010 - Elsevier
PURPOSE: To evaluate mycophenolate mofetil as a single noncorticosteroid
immunosuppressive treatment for noninfectious ocular inflammatory diseases. DESIGN …

Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis

HN Khanamiri, NA Rao - Survey of ophthalmology, 2013 - Elsevier
Serpiginous choroiditis (SC) is a posterior uveitis displaying a geographic pattern of
choroiditis, extending from the juxtapapillary choroid and intermittently spreading …

Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye …

AC Gregory II, JH Kempen, E Daniel, RO Kaçmaz… - Ophthalmology, 2013 - Elsevier
PURPOSE: To describe the incidence of and risk factors for visual acuity (VA) loss and
ocular complications in patients with juvenile idiopathic arthritis (JIA)–associated uveitis …